DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,042 filers reported holding DANAHER CORPORATION in Q3 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $987,438 | +15.7% | 3,980 | +12.0% | 0.03% | +17.9% |
Q2 2023 | $853,200 | -32.9% | 3,555 | -29.5% | 0.03% | -34.9% |
Q1 2023 | $1,270,786 | +6.0% | 5,042 | +11.6% | 0.04% | +2.4% |
Q4 2022 | $1,198,902 | -26.8% | 4,517 | -28.7% | 0.04% | -32.3% |
Q3 2022 | $1,637,000 | -2.6% | 6,337 | -4.5% | 0.06% | 0.0% |
Q2 2022 | $1,681,000 | -5.6% | 6,633 | +9.3% | 0.06% | +3.3% |
Q1 2022 | $1,780,000 | +95.6% | 6,069 | +119.3% | 0.06% | +87.5% |
Q4 2021 | $910,000 | +43.8% | 2,767 | +33.1% | 0.03% | +28.0% |
Q3 2021 | $633,000 | +441.0% | 2,079 | +214.5% | 0.02% | +257.1% |
Q2 2020 | $117,000 | +515.8% | 661 | +379.0% | 0.01% | +600.0% |
Q1 2020 | $19,000 | +46.2% | 138 | +68.3% | 0.00% | 0.0% |
Q4 2019 | $13,000 | +30.0% | 82 | +17.1% | 0.00% | 0.0% |
Q3 2019 | $10,000 | 0.0% | 70 | 0.0% | 0.00% | 0.0% |
Q2 2019 | $10,000 | -67.7% | 70 | -77.8% | 0.00% | -66.7% |
Q2 2018 | $31,000 | +3.3% | 316 | -3.4% | 0.00% | +50.0% |
Q4 2017 | $30,000 | +7.1% | 327 | 0.0% | 0.00% | 0.0% |
Q3 2017 | $28,000 | +3.7% | 327 | +3.5% | 0.00% | 0.0% |
Q2 2017 | $27,000 | +440.0% | 316 | +532.0% | 0.00% | +100.0% |
Q4 2015 | $5,000 | +25.0% | 50 | 0.0% | 0.00% | 0.0% |
Q3 2015 | $4,000 | 0.0% | 50 | 0.0% | 0.00% | 0.0% |
Q2 2015 | $4,000 | 0.0% | 50 | 0.0% | 0.00% | 0.0% |
Q1 2015 | $4,000 | – | 50 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
Third Point | 3,570,000 | $494,124,000 | 7.88% |